AAAAAA
Results: 26-50/640
Authors:
LESQUESNE M
CADET C
Citation: M. Lesquesne et C. Cadet, DO CHONDROPROTECTIVE AGENTS EXIST IN OSTE OARTHRITIS TREATMENT - REQUIRED PROOFS, Therapie, 53(1), 1998, pp. 7-16
Authors:
BERTIN P
GILLET P
TREVES R
NETTER P
Citation: P. Bertin et al., DO SOME DRUGS INDUCE ADVERSE EVENTS ON CA RTILAGE, Therapie, 53(1), 1998, pp. 17-20
Authors:
NIEOULLON A
Citation: A. Nieoullon, CELLULAR BASIS OF NEURODEGENERATIVE PROCE SSES, Therapie, 53(1), 1998, pp. 21-29
Authors:
FINIELS F
Citation: F. Finiels, PHARMACOLOGY OF DEGENERATIVE DISEASES - P ERSPECTIVES ON CELL AND GENE THERAPIES, Therapie, 53(1), 1998, pp. 31-34
Authors:
SENARD JM
MONTASTRUC JL
Citation: Jm. Senard et Jl. Montastruc, PHARMACOLOGY OF AUTONOMIC FAILURE, Therapie, 53(1), 1998, pp. 35-41
Authors:
RASCOL O
BREFELCOURBON C
BLIN O
Citation: O. Rascol et al., CLINICAL-PHARMACOLOGY OF L-DOPA-INDUCED D YSKINESIAS IN PARKINSONIAN-PATIENTS, Therapie, 53(1), 1998, pp. 43-48
Authors:
ROZENBAUM H
Citation: H. Rozenbaum, WHY IS MENOPAUSE BECOMING A PUBLIC-HEALTH PROBLEM, Therapie, 53(1), 1998, pp. 49-59
Authors:
JOLLIET P
BOURIN M
Citation: P. Jolliet et M. Bourin, UROSELECTIVITY OF ALPHA-1-ADRENERGIC ANTA GONISTS IN BENIGN PROSTATICHYPERPLASIA, Therapie, 53(1), 1998, pp. 61-66
Authors:
ESTADIEU MC
MACHOU C
BERTHEZENE P
PASTOR MJ
ANGELINI B
BOHOR M
BONGRAND MC
TIMONDAVID P
GASTAUT JL
ALLAIN H
MICHEL BF
Citation: Mc. Estadieu et al., TOLERANCE-EFFICACY OUTCOME OF ONE-YEAR OF TACRINE UTILIZATION IN 100 ALZHEIMERS-DISEASE CASES, Therapie, 53(1), 1998, pp. 67-76
Authors:
CHEVREL G
MOREAU T
VIAL T
PAYEN C
CONFAVREUX C
Citation: G. Chevrel et al., AZATHIOPRINE HYPERSENSITIVITY CAN STIMULA TE A WORSENING OF MYASTHENIA-GRAVIS, Therapie, 53(1), 1998, pp. 77-78
Authors:
DAVID M
BRETON JL
GUY I
VANDEL S
Citation: M. David et al., ZOPICLONE AND DELIRIUM - A CASE-REPORT, Therapie, 53(1), 1998, pp. 78-80
Authors:
SADEG N
DESCHAMPS P
DUMONTET M
Citation: N. Sadeg et al., AMFEPRAMONE OVERDOSE, Therapie, 53(1), 1998, pp. 80-81
Authors:
BAGHERI H
BROUE P
LACROIX I
LARREY D
OLIVES JP
VAYSSE P
GHISOLFI J
MONTASTRUC JL
Citation: H. Bagheri et al., FULMINANT HEPATIC-FAILURE AFTER HERBAL MEDICINE INGESTION IN CHILDREN, Therapie, 53(1), 1998, pp. 82-83
Authors:
SASSARD J
Citation: J. Sassard, THE PRESIDENTS PAGE, Therapie, 52(6), 1997, pp. 526-526
Authors:
SOUBROUILLARD C
LOMBARDO C
RASCOL O
BRUGUEROLLE B
BLIN O
Citation: C. Soubrouillard et al., CENTRAL DOPAMINERGIC D1 AGONISTS IN THE T REATMENT OF PARKINSONS-DISEASE, Therapie, 52(6), 1997, pp. 527-534
Authors:
LEPAILLIER R
VARLAN E
Citation: R. Lepaillier et E. Varlan, MULTICRITERION ANALYSIS - METHOD AND APPL ICATION FOR THE SELECTION OF MOLECULES IN THE CARDIOVASCULAR DOMAIN, Therapie, 52(6), 1997, pp. 535-543
Authors:
LEPAILLIER R
Citation: R. Lepaillier, THE NUMERIC CASE-REPORT FORMS - REALIZATI ON AND PRACTICAL UTILIZATION IN THE CARDIOVASCULAR DOMAIN, Therapie, 52(6), 1997, pp. 545-551
Authors:
FAURE C
GASSER P
DOUET MC
Citation: C. Faure et al., EVALUATION OF THE COST OF CARE OF PATIENT S INFECTED WITH HEPATITIS-CVIRUS, Therapie, 52(6), 1997, pp. 553-558
Authors:
LEPAUX DJ
BRIANCON S
LECOMPTE T
DELORME N
PINELLI C
Citation: Dj. Lepaux et al., CLINICAL-PRACTICE SURVEY APPLIED TO DRUG- USE IN-HOSPITAL - CONCEPTS AND METHODOLOGY, Therapie, 52(6), 1997, pp. 559-567
Authors:
FRANCOIS P
BONTEMPS H
BERTRAND D
BOSSON JL
CALOP J
Citation: P. Francois et al., SURVEY OF PRESCRIPTION-WRITING QUALITY IN -HOSPITAL, Therapie, 52(6), 1997, pp. 569-571
Authors:
HIDA H
FABER M
ALBERTOGONDOUIN MC
JALAGUIER E
Citation: H. Hida et al., A SURVEY OF PSYCHOTROPIC-DRUG PRESCRIBING IN A PSYCHIATRIC-HOSPITAL, Therapie, 52(6), 1997, pp. 573-578
Authors:
DETRICORNOT B
SADDIER P
BONS B
CLEMENT JP
COURTAND M
LAMARQUE V
THOMAS A
TOMCZYK S
VAISSERE J
Citation: B. Detricornot et al., PROPOSAL OF GUIDELINES FOR THE SAFE SET-U P OF PHARMACOEPIDEMIOLOGIC STUDIES, Therapie, 52(6), 1997, pp. 579-585
Authors:
CHAMPEL V
JONVILLEBERA AP
BERA F
AUTRET E
Citation: V. Champel et al., ESOPHAGEAL INJURIES ASSOCIATED WITH TETRA CYCLINE THERAPY (A SURVEY BY THE FRENCH REGIONAL PHARMACOVIGILANCE CENTERS), Therapie, 52(6), 1997, pp. 587-589
Authors:
GINDRE J
DEMAISTRE E
PERRIN A
LECOMPTE T
HOFFMAN MA
Citation: J. Gindre et al., USE OF DANAPAROID (ORGARAN(R)) - ABOUT 13 MONOCENTRIC CASES UNDER THEREGULATION OF TEMPORARY AUTHORIZATION FOR PRESCRIBING MEDICINES (ATU), Therapie, 52(6), 1997, pp. 591-597
Authors:
VAUR L
GENES N
CHAMBRELAN F
DUTREYDUPAGNE C
POCHOY A
ELKIK F
RAUSS A
Citation: L. Vaur et al., INTOLERANCE RISK-FACTORS FOR THE ACE-INHI BITOR TRANDOLAPRIL - A STUDY ON 30,072 PATIENTS, Therapie, 52(6), 1997, pp. 599-605